IRIS

Sfoglia per ???browse.type.metadata.subjectIsicrui???  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 37 a 56 di 256
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-1989 Chromosome breakage induced by bleomycin in an ataxia telangiectasia lymphoblastoid line: correlation with fragile sites and Epstein-Barr virus DNA localization Caporossi, D; Tedeschi, B; Vernole, P; Porfirio, B; Nicoletti, B Articolo su rivista
1-mag-2006 Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir Trotta, M; Bonfigli, S; CECCHERINI SILBERSTEIN, F; Bellagamba, R; D'Arrigo, R; Soldani, F; Zaccarelli, M; Concetta Bellocchi, M; Lorenzini, P; Marconi, P; Boumis, E; Forbici, F; Comandini, U; Tozzi, V; Narciso, P; Perno, Cf; Antinori, A Articolo su rivista
22-ago-2006 Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART Marchetti, G; Gori, A; Casabianca, A; Magnani, M; Franzetti, F; Clerici, M; Perno, Cf; Monforte, A; Galli, M; Meroni, L Articolo su rivista
1-gen-2010 Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients. Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Chiarella, V; Dimonte, S; Ortuso, F; Perno, Cf Articolo su rivista
1-gen-2010 Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Chiarella, V; Dimonte, S; Ortuso, F; Perno, Cf Articolo su rivista
1-ago-2004 Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes De Luca, A; Vendittelli, M; Baldini, F; Di Giambenedetto, S; Trotta, M; Cingolani, A; Bacarelli, A; Gori, C; Perno, Cf; Antinori, A; Ulivi, G Articolo su rivista
1-gen-1997 Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'- dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus Balzarini, J; Kruining, J; Wedgwood, O; Pannecouque, C; Aquaro, S; Perno, Cf; Naesens, L; Witvrouw, M; Heijtink, R; De Clercq, E; Mcguigan, C Articolo su rivista
31-lug-2010 Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study Lodwick, R; Sabin, C; Porter, K; Ledergerber, B; van Sighem, A; Cozzi Lepri, A; Khaykin, P; Mocroft, A; Jacobson, L; De Wit, S; Obel, N; Castagna, A; Wasmuth, J; Gill, J; Klein, M; Gange, S; Riera, M; Mussini, C; Gutiérrez, F; Touloumi, G; Carrieri, P; Guest, J; Brockmeyer, N; Phillips, A; Perno, Cf Articolo su rivista
1-apr-2008 Detection of oncogenic DNA viruses in colorectal cancer Giuliani, L; Ronci, C; Bonifacio, D; Di Bonito, L; Favalli, C; Perno, Cf; Syrjänen, K; Ciotti, M Articolo su rivista
1-mag-2014 Di-(2-ethylhexyl) phthalate and bisphenol A exposure impairs mouse primordial follicle assembly in vitro Zhang, T; Li, L; Qin, X; Zhou, Y; Zhang, X; Wang, L; DE FELICI, M; Chen, H; Qin, G; Shen, W Articolo su rivista
1-nov-2010 Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf Articolo su rivista
1-nov-2010 Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf Articolo su rivista
1-ago-2012 Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. Butini, S; Brindisi, M; Gemma, S; Minetti, P; Cabri, W; Gallo, G; Vincenti, S; Talamonti, E; Borsini, F; Caprioli, A; Stasi, M; Di Serio, S; Ros, S; Borrelli, G; Maramai, S; Fezza, F; Campiani, G; Maccarrone, M Articolo su rivista
9-dic-2011 Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V Articolo su rivista
1-gen-2006 Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? Aquaro, S; Svicher, V; Perno, Cf Articolo su rivista
1-gen-2006 Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome Tozzi, V; Zaccarelli, M; Bonfigli, S; Lorenzini, P; Liuzzi, G; Trotta, M; Forbici, F; Gori, C; Bertoli, A; Bellagamba, R; Narciso, P; Perno, Cf; Antinori, A Articolo su rivista
1-gen-1996 Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo Bagnarelli, P; Valenza, A; Menzo, S; Sampaolesi, R; Varaldo, P; Butini, L; Montroni, M; Perno, Cf; Aquaro, S; Mathez, D; Leibowitch, J; Balotta, C; Clementi, M Articolo su rivista
1-gen-2009 Dynamics of NRTI resistance mutations during therapy interruption Trignetti, M; Sing, T; Svicher, V; Santoro, M; Forbici, F; D'Arrigo, R; Bellocchi, M; Santoro, M; Marconi, P; Zaccarelli, M; Trotta, M; Bellagamba, R; Narciso, P; Antinori, A; Lengauer, T; Perno, Cf; CECCHERINI SILBERSTEIN, F Articolo su rivista
1-giu-2009 Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure Zaccarelli, M; Lorenzini, P; Tozzi, V; Forbici, F; CECCHERINI SILBERSTEIN, F; Gori, C; D'Arrigo, R; Trotta, M; Narciso, P; Perno, Cf; Antinori, A Articolo su rivista
1-ago-2009 Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility Puertas, M; Buzon, M; Artese, A; Alcaro, S; Menendez Arias, L; Perno, Cf; Clotet, B; CECCHERINI SILBERSTEIN, F; Martinez Picado, J Articolo su rivista
Mostrati risultati da 37 a 56 di 256
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile